Welcome to our Women's Health Community
A resource centre for healthcare professionals working in women's health, including vaginal health, VVA and menopause.
Women's Health: Vaginal dryness is a common problem during the menopause, but it is something women rarely talk about. We aim to raise awareness of the impact of VVA on women's health, with the ambition of bringing about positive change to those whose lives are affected by this diagnosis.
Menopause: We work with leading experts in the field to design meeting programmes that explore key issues in menopause whilst offering practical tips and training that are applicable for use in the real world.
Vulvar and Vaginal Atrophy (VVA): Flynn has collaborated with clinicians and leaders working within the NHS and elsewhere to create a range of healthcare professional and patient-focussed resources to support the patient journey.
Latest Events
We are committed to the delivery of high quality education and supporting the continued development of healthcare professionals - it's our way of helping you to help your patients. Here are the latest educational events across our community.
Featured Event
2023 dates coming soon
No results found.
Become a Women's health Community Member
Join our community as a Member and keep up to date on the latest developments.
Latest Education and Training
Flynn is committed to supporting the continued education of healthcare professionals, trainees and allied roles in Women’s Health. Free resources for HCPs and patient information in women’s health. Resources are fully searchable and categorised by therapy area, condition, format and products.
Blissel® – A Case Study
A material designed to support health care professionals to initiate a discussion with patients around signs and symptoms of Vulvovaginal Atrophy using a patient case study.
Information Leaflet for Patients Prescribed Blissel®
A leaflet designed for patients to support them in how to use Blissel® (estriol 50 micrograms/g vaginal gel).
Let’s Talk About VVA
Vulvovaginal Atrophy (VVA) is commonly under-reported and underdiagnosed. This factsheet discusses why and when to use intravaginal estrogens and helps healthcare professionals differentiate between different preparations.
Request a meeting
Send a virtual meeting request
VVA Treatment Comparison Table1
Vulvovaginal atrophy is a common and underreported menopausal condition arising from decreased oestrogenisation of the vaginal tissue.
This resource has been created by consensus by
the PCWHF. It compares the different types of treatment for VVA, including useful expert notes agreed by GPs and menopause specialists working in primary care. It provides useful advice on treatment options and support.
It was produced with an unrestricted grant from Flynn Pharma Ltd.
References
1. Primary Care Women’s Health Forum, Vulvovaginal atrophy (VVA) Treatment Comparison Table, November 2021